HTL Biotechnology
HTL Biotechnology in Brittany (a more than 64,000 m² site) is a global leader in pharmaceutical-grade biopolymers, running fermentation through extraction and purification on a solvent-free route and inaugurating a new sterile hyaluronic-acid production line on 6 June 2025.
- Country
- France
Pharma-grade HA biopolymer
GMP / solvent-free
eu
Coverage
| CN | EU | US | |
|---|---|---|---|
| fibers-textiles | ✓ | ✓ | ✓ |
| specialty-fine-chem | ✓ | ✓ | ✓ |
Regulatorsfdaemanmpa
Technologies
| Name | Cluster | Risk | |
|---|---|---|---|
| Biosynthetic hyaluronic acid | specialty-fine-chem | Low | → |
| Recombinant collagen & gelatin | fibers-textiles | Medium | → |
Compiled by BIOECON via the bioecon-brief pipeline.
Compliance
Bioecon is an information intermediary; it is not a regulator, a certification body, or a legal advisor. When working with public-sector customers (procurement under 44-FZ / 223-FZ), Bioecon acts solely as an independent analytical platform, with no remuneration from suppliers.